|
-Contraindicated in renal artery stenosis
|
| bet | 100/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
-Contraindicated in renal artery stenosis
Supplied as :
|
A clear, colourless, plum flavoured syrup containing 5000 microg/ml of solution. May be diluted with water for lower doses
When syrup is unavailable, disperse one tablet in water to make a 1000 microg/mL mixture. Discard unused portion immediately after preparation.
|
Dilution :
|
Dilute 1 ml of syrup with 4 ml of water to make 1 mg/ml solution. Administer immediately and discard remainder after use.
|
Stability :
|
may be kept up to 28 days after opening.
|
Storage :
|
Store oral solution in the refrigerator between 2-8 degrees. Discard oral solution 28 days after opening bottle
|
Incompatibility :
|
Not Applicable.
|
Serum Levels :
|
Not Applicable.
|
|
|
References:
Truven Health Analytics. Captopril. In: NeoFax [Internet]. Greenwood Village (CO): Truven Health Analytics; 2020 [cited 23-12-2020]. Available from: https://neofax.micromedexsolutions.com/
Ainsworth SB. Neonatal formulary 7: drug use in pregnancy and the first year of life. Seventh ed. Chichester (West Sussex): John Wiley & Sons Inc.; 2015. P124.
Takemoto CK, Hodding JH, Kraus DM. Pediatric & neonatal dosage handbook with international trade names index : a universal resource for clinicians treating pediatric and neonatal patients. 24th ed. Hudson (Ohio): Lexicomp; 2019. P346-9.
British National Formulary. BNF for Children. 2018-19 ed. London, UK: BMJ Group and Pharmaceutical Press; 2018.
Original version Date: 9/1/2014
|
Author: AK, JD
|
Current Version number: 2
|
Version Date: 23/12/2020
|
Risk Rating: Medium
|
Due for Review: 23/12/2025
|
Approval by: DTC
|
Approval Date: TBA
|
|
| |
